Annual Cash & Cash Equivalents
$453.93 M
+$341.39 M+303.33%
31 December 2023
Summary:
IDEXX Laboratories annual cash & cash equivalents is currently $453.93 million, with the most recent change of +$341.39 million (+303.33%) on 31 December 2023. During the last 3 years, it has risen by +$70.00 million (+18.23%). IDXX annual cash & cash equivalents is now at all-time high.IDXX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$308.64 M
-$92.95 M-23.15%
30 September 2024
Summary:
IDEXX Laboratories quarterly cash and cash equivalents is currently $308.64 million, with the most recent change of -$92.95 million (-23.15%) on 30 September 2024. Over the past year, it has dropped by -$23.06 million (-6.95%). IDXX quarterly cash and cash equivalents is now -32.01% below its all-time high of $453.93 million, reached on 31 December 2023.IDXX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +303.3% | -7.0% |
| 3 y3 years | +18.2% | +112.5% |
| 5 y5 years | +266.7% | +196.8% |
IDXX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +303.3% | -32.0% | +211.2% |
| 5 y | 5 years | at high | +402.6% | -32.0% | +279.2% |
| alltime | all time | at high | +4781.0% | -32.0% | >+9999.0% |
IDEXX Laboratories Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $308.64 M(-23.1%) |
| June 2024 | - | $401.59 M(+1.0%) |
| Mar 2024 | - | $397.43 M(-12.4%) |
| Dec 2023 | $453.93 M(+303.3%) | $453.93 M(+36.9%) |
| Sept 2023 | - | $331.70 M(+149.7%) |
| June 2023 | - | $132.84 M(+19.3%) |
| Mar 2023 | - | $111.37 M(-1.0%) |
| Dec 2022 | $112.55 M(-22.1%) | $112.55 M(+13.5%) |
| Sept 2022 | - | $99.18 M(-13.3%) |
| June 2022 | - | $114.36 M(-44.1%) |
| Mar 2022 | - | $204.62 M(+41.6%) |
| Dec 2021 | $144.45 M(-62.4%) | $144.45 M(-0.5%) |
| Sept 2021 | - | $145.20 M(-37.4%) |
| June 2021 | - | $232.13 M(-33.9%) |
| Mar 2021 | - | $351.16 M(-8.5%) |
| Dec 2020 | $383.93 M(+325.0%) | $383.93 M(+118.7%) |
| Sept 2020 | - | $175.59 M(+66.8%) |
| June 2020 | - | $105.29 M(+29.4%) |
| Mar 2020 | - | $81.39 M(-9.9%) |
| Dec 2019 | $90.33 M(-27.0%) | $90.33 M(-13.1%) |
| Sept 2019 | - | $104.00 M(-6.2%) |
| June 2019 | - | $110.84 M(-4.9%) |
| Mar 2019 | - | $116.62 M(-5.8%) |
| Dec 2018 | $123.79 M(-34.0%) | $123.79 M(-15.7%) |
| Sept 2018 | - | $146.88 M(-15.9%) |
| June 2018 | - | $174.56 M(+9.6%) |
| Mar 2018 | - | $159.23 M(-15.2%) |
| Dec 2017 | $187.68 M(+21.2%) | $187.68 M(+11.0%) |
| Sept 2017 | - | $169.02 M(+1.8%) |
| June 2017 | - | $165.97 M(+3.5%) |
| Mar 2017 | - | $160.41 M(+3.6%) |
| Dec 2016 | $154.90 M(+20.1%) | $154.90 M(+3.2%) |
| Sept 2016 | - | $150.07 M(+6.3%) |
| June 2016 | - | $141.14 M(+6.2%) |
| Mar 2016 | - | $132.95 M(+3.1%) |
| Dec 2015 | $128.99 M(-60.0%) | $128.99 M(-8.6%) |
| Sept 2015 | - | $141.15 M(-13.5%) |
| June 2015 | - | $163.15 M(-10.4%) |
| Mar 2015 | - | $182.16 M(-43.5%) |
| Dec 2014 | $322.54 M(+15.6%) | $322.54 M(+10.2%) |
| Sept 2014 | - | $292.74 M(-4.0%) |
| June 2014 | - | $305.05 M(+6.6%) |
| Mar 2014 | - | $286.20 M(+2.6%) |
| Dec 2013 | $279.06 M(+24.6%) | $279.06 M(+5.4%) |
| Sept 2013 | - | $264.81 M(+5.5%) |
| June 2013 | - | $251.01 M(+9.9%) |
| Mar 2013 | - | $228.36 M(+2.0%) |
| Dec 2012 | $223.99 M(+21.8%) | $223.99 M(+1.1%) |
| Sept 2012 | - | $221.44 M(+9.7%) |
| June 2012 | - | $201.81 M(+8.8%) |
| Mar 2012 | - | $185.49 M(+0.9%) |
| Dec 2011 | $183.90 M(+17.2%) | $183.90 M(+1.3%) |
| Sept 2011 | - | $181.50 M(+13.9%) |
| June 2011 | - | $159.40 M(+3.9%) |
| Mar 2011 | - | $153.46 M(-2.2%) |
| Dec 2010 | $156.91 M(+47.0%) | $156.91 M(+17.5%) |
| Sept 2010 | - | $133.51 M(+13.2%) |
| June 2010 | - | $117.97 M(+10.9%) |
| Mar 2010 | - | $106.35 M(-0.4%) |
| Dec 2009 | $106.73 M(+35.3%) | $106.73 M(0.0%) |
| Sept 2009 | - | $106.73 M(+2.9%) |
| June 2009 | - | $103.74 M(+20.2%) |
| Mar 2009 | - | $86.30 M(+9.4%) |
| Dec 2008 | $78.87 M(+30.7%) | $78.87 M(-6.8%) |
| Sept 2008 | - | $84.59 M(+12.4%) |
| June 2008 | - | $75.27 M(+25.0%) |
| Mar 2008 | - | $60.22 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $60.36 M(-2.1%) | $60.36 M(+3.2%) |
| Sept 2007 | - | $58.51 M(+18.0%) |
| June 2007 | - | $49.59 M(-8.1%) |
| Mar 2007 | - | $53.94 M(-12.5%) |
| Dec 2006 | $61.67 M(-8.2%) | $61.67 M(+21.0%) |
| Sept 2006 | - | $50.95 M(+1.9%) |
| June 2006 | - | $50.02 M(+41.6%) |
| Mar 2006 | - | $35.34 M(-47.4%) |
| Dec 2005 | $67.15 M(+42.4%) | $67.15 M(+16.2%) |
| Sept 2005 | - | $57.77 M(+10.3%) |
| June 2005 | - | $52.35 M(+17.4%) |
| Mar 2005 | - | $44.58 M(-5.5%) |
| Dec 2004 | $47.16 M(-51.4%) | $47.16 M(-67.8%) |
| Sept 2004 | - | $146.53 M(-11.0%) |
| June 2004 | - | $164.66 M(-8.8%) |
| Mar 2004 | - | $180.51 M(+86.2%) |
| Dec 2003 | $96.94 M(-14.8%) | $96.94 M(-45.2%) |
| Sept 2003 | - | $176.86 M(+16.8%) |
| June 2003 | - | $151.43 M(+13.5%) |
| Mar 2003 | - | $133.45 M(+17.3%) |
| Dec 2002 | $113.79 M(+70.7%) | $113.79 M(+8.2%) |
| Sept 2002 | - | $105.20 M(+53.4%) |
| June 2002 | - | $68.57 M(-15.8%) |
| Mar 2002 | - | $81.48 M(+22.2%) |
| Dec 2001 | $66.67 M(+44.9%) | $66.67 M(-3.4%) |
| Sept 2001 | - | $69.04 M(+39.5%) |
| June 2001 | - | $49.49 M(+77.6%) |
| Mar 2001 | - | $27.87 M(-39.4%) |
| Dec 2000 | $46.01 M(-21.5%) | $46.01 M(+18.8%) |
| Sept 2000 | - | $38.73 M(-47.4%) |
| June 2000 | - | $73.65 M(+7.7%) |
| Mar 2000 | - | $68.37 M(+16.7%) |
| Dec 1999 | $58.58 M(-46.3%) | $58.58 M(-21.6%) |
| Sept 1999 | - | $74.70 M(-30.3%) |
| June 1999 | - | $107.10 M(+17.3%) |
| Mar 1999 | - | $91.30 M(-16.3%) |
| Dec 1998 | $109.10 M(+2.0%) | $109.10 M(-21.3%) |
| Sept 1998 | - | $138.70 M(+7.0%) |
| June 1998 | - | $129.60 M(+19.0%) |
| Mar 1998 | - | $108.90 M(+1.8%) |
| Dec 1997 | $107.00 M(-16.2%) | $107.00 M(+1.4%) |
| Sept 1997 | - | $105.50 M(-11.5%) |
| June 1997 | - | $119.20 M(+8.6%) |
| Mar 1997 | - | $109.80 M(-14.0%) |
| Dec 1996 | $127.70 M(-14.5%) | $127.70 M(+1.8%) |
| Sept 1996 | - | $125.50 M(-10.0%) |
| June 1996 | - | $139.40 M(+8.3%) |
| Mar 1996 | - | $128.70 M(-13.8%) |
| Dec 1995 | $149.30 M(+492.5%) | $149.30 M(-19.6%) |
| Sept 1995 | - | $185.80 M(+489.8%) |
| June 1995 | - | $31.50 M(-9.2%) |
| Mar 1995 | - | $34.70 M(+37.7%) |
| Dec 1994 | $25.20 M(+33.3%) | $25.20 M(+22.3%) |
| Sept 1994 | - | $20.60 M(-8.0%) |
| June 1994 | - | $22.40 M(+1.4%) |
| Mar 1994 | - | $22.10 M(+16.9%) |
| Dec 1993 | $18.90 M(+9.9%) | $18.90 M(-12.5%) |
| Sept 1993 | - | $21.60 M(+0.5%) |
| June 1993 | - | $21.50 M(+7.5%) |
| Mar 1993 | - | $20.00 M(+16.3%) |
| Dec 1992 | $17.20 M(+84.9%) | $17.20 M(+30.3%) |
| Sept 1992 | - | $13.20 M(+14.8%) |
| June 1992 | - | $11.50 M(+422.7%) |
| Mar 1992 | - | $2.20 M(-76.3%) |
| Dec 1991 | $9.30 M | $9.30 M(-9.7%) |
| Sept 1991 | - | $10.30 M(-50.5%) |
| June 1991 | - | $20.80 M |
FAQ
- What is IDEXX Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IDEXX Laboratories?
- What is IDEXX Laboratories annual cash & cash equivalents year-on-year change?
- What is IDEXX Laboratories quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly cash and cash equivalents year-on-year change?
What is IDEXX Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of IDXX is $453.93 M
What is the all time high annual cash & cash equivalents for IDEXX Laboratories?
IDEXX Laboratories all-time high annual cash & cash equivalents is $453.93 M
What is IDEXX Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, IDXX annual cash & cash equivalents has changed by +$341.39 M (+303.33%)
What is IDEXX Laboratories quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IDXX is $308.64 M
What is the all time high quarterly cash and cash equivalents for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly cash and cash equivalents is $453.93 M
What is IDEXX Laboratories quarterly cash and cash equivalents year-on-year change?
Over the past year, IDXX quarterly cash and cash equivalents has changed by -$23.06 M (-6.95%)